UTI - Healthcare Fund

ThematicDirect and Regular plans, Growth and IDCW options

Data as on 30-10-2026

UTI - Healthcare Fund is a Thematic fund run by UTI Mutual Fund. On 30-09-2026, it managed ₹1,430 Cr of investors' money. In the 3 years to 30-10-2026, its Direct plan returned 23.5% a year and its Regular plan returned 22.3% a year. Its benchmark, BSE Healthcare TRI, returned 23.0% a year over the same 3 years.

NAV (Direct plan): ₹375.09; ▼ 0.13%30-10-2026
NAV (Regular plan): ₹328.62; ▼ 0.14%30-10-2026
Expense ratio: 1.35%Direct2.23%Regular; 1.35%; A year
Riskometer: Very High; Set by the fund house
3 year return: 23.5%Direct22.3%Regular; 23.5%; A year

UTI - Healthcare Fund NAV Today

NAV on 30-10-2026: Direct Plan Growth ₹375.09 (down 0.13% that day); Regular Plan Growth ₹328.62 (down 0.14% that day).

This fund (Direct plan)

₹375.0929

UTI - Healthcare Fund Returns vs BSE Healthcare TRI

Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.

Trailing returns
Period	1M	3M	6M	1Y	3Y	5Y	10Y
This fund (Direct)	−1.26%	−1.40%	+12.80%	+13.46%	+23.47%	+16.24%	+14.40%
This fund (Regular)	−1.33%	−1.63%	+12.28%	+12.39%	+22.28%	+15.06%	+13.26%
BSE Healthcare TRI	+0.24%	−0.99%	+12.80%	+12.37%	+23.01%	+15.61%	+12.48%
Thematic average	−2.09%	−4.52%	+0.86%	−1.22%	+13.76%	+11.62%	+13.76%
Best in Thematic	+11.54%	+11.27%	+22.16%	+75.71%	+54.78%	+21.14%	+19.31%
Worst in Thematic	−16.05%	−11.74%	−13.97%	−22.44%	−4.46%	+3.65%	+7.72%
Rank in Thematic	74/235	47/232	17/232	18/215	8/133	21/96	28/63

Category rows compare the Direct plans of 235 Thematic funds. Rank 1 is the highest return.

UTI - Healthcare Fund Year-wise Returns

Return of each calendar year
Year	Direct	Regular	BSE Healthcare TRI
2026to date	+16.63%	+15.72%	+15.08%
2025	−2.18%	−3.15%	−2.72%
2024	+44.27%	+42.86%	+44.30%
2023	+39.56%	+38.20%	+37.97%
2022	−11.30%	−12.32%	−11.50%
2021	+20.35%	+19.08%	+21.54%

UTI - Healthcare Fund Rolling Returns

The return of every holding period in the fund's history, not only the one that ends today

Rolling returns

Each point is the yearly return of one 3-year holding period, plotted on the day it ended. There are 2,666 periods, one for each trading day from 04-01-2016 to 30-10-2026.

−10%0%10%20%30%

Nov 2013
to
Nov 2016Sept 2015
to
Sept 2018Jul 2017
to
Jul 2020May 2019
to
May 2022Mar 2021
to
Mar 2024Dec 2022
to
Dec 2025

UTI - Healthcare Fund (Direct)BSE Healthcare TRI

Every holding period at a glance

Period	Periods	Median	Lowest	Highest	With a loss	Benchmark median	Beat benchmark
1 year	3,154	12.7%	−17.9%	86.3%	31%	11.5%	67%
2 years	2,912	15.1%	−12.0%	52.5%	24%	12.8%	76%
3 years	2,666	17.9%	−6.5%	29.7%	16%	17.0%	90%
5 years	2,173	13.7%	−4.5%	32.4%	2%	11.3%	99%
7 years	1,684	14.3%	6.0%	25.1%	0%	12.1%	100%
10 years	941	13.8%	10.2%	15.6%	0%	11.9%	100%

Every SIP holding period at a glance

Period	Periods	Median	Lowest	Highest	With a loss	Benchmark median	Beat benchmark
1 year	154	8.9%	−21.3%	85.5%	29%	7.6%	68%
2 years	142	12.5%	−10.9%	56.1%	25%	12.4%	73%
3 years	130	14.6%	−6.7%	40.0%	20%	14.1%	87%
5 years	106	17.6%	−4.3%	30.4%	8%	15.2%	99%
7 years	82	16.8%	1.2%	26.3%	0%	14.6%	100%
10 years	46	17.2%	10.1%	19.9%	0%	15.9%	100%

Lumpsum: the yearly rate (CAGR) from the NAV on a period's first day to the NAV on its last. SIP: the XIRR of the monthly instalments and their value on the last day. "With a loss" counts the periods that ended below the money put in. "Beat benchmark" counts the periods in which the fund did better than BSE Healthcare TRI over the same days. Past returns do not promise future returns.

UTI - Healthcare Fund Risk

How much it swings, and the falls an investor had to sit through

Risk and return

Measure	UTI - Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+13.46%	+12.37%
Standard deviation	13.22%	13.56%
Sharpe ratio	0.62	0.53
Sortino ratio	0.91	0.77
Maximum drawdown	−10.2% (23-10-2026)	−9.9% (23-10-2026)
Beta	0.93	1.00
Alpha	+1.60%	0.00%

From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	UTI - Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+23.47%	+23.01%
Standard deviation	13.47%	14.12%
Sharpe ratio	1.30	1.20
Sortino ratio	1.84	1.71
Maximum drawdown	−15.9% (03-03-2025)	−16.2% (28-02-2025)
Beta	0.92	1.00
Alpha	+1.87%	0.00%

From daily NAVs, 30-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	UTI - Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+16.24%	+15.61%
Standard deviation	13.13%	13.97%
Sharpe ratio	0.79	0.70
Sortino ratio	1.12	1.00
Maximum drawdown	−19.4% (17-06-2022)	−19.6% (17-06-2022)
Beta	0.91	1.00
Alpha	+1.53%	0.00%

From daily NAVs, 29-10-2021 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	UTI - Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+14.40%	+12.48%
Standard deviation	15.08%	16.56%
Sharpe ratio	0.60	0.43
Sortino ratio	0.85	0.60
Maximum drawdown	−22.6% (23-03-2020)	−31.6% (23-03-2020)
Beta	0.88	1.00
Alpha	+2.77%	0.00%

From daily NAVs, 28-10-2016 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	UTI - Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+16.09%	+14.72%
Standard deviation	15.17%	16.65%
Sharpe ratio	0.66	0.52
Sortino ratio	0.94	0.73
Maximum drawdown	−27.1% (23-03-2020)	−38.8% (23-03-2020)
Beta	0.88	1.00
Alpha	+2.36%	0.00%

From daily NAVs, 02-01-2013 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Drawdowns

How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.

−40%−30%−20%−10%0%

2014201620182020202220242026

UTI - Healthcare Fund (Direct)BSE Healthcare TRI

	Worst fall	High before it	Bottom	Back at the high	Time to climb back	Below its high today
UTI - Healthcare Fund (Direct)	−27.1%	08-04-2015	23-03-2020	27-04-2020	35 days	−5.0%
BSE Healthcare TRI	−38.8%	08-04-2015	23-03-2020	31-07-2020	4 months	−3.8%

From the Direct plan's daily NAV since 02-01-2013, adjusted for unit splits, and BSE Healthcare TRI over the same days. "Time to climb back" runs from the bottom to the first day back at the old high.

UTI - Healthcare Fund vs Other Thematic Funds

The five Thematic funds with the best three year return, and this fund. Direct plans.

Fund name	Rank	AUM (Cr)	Exp. ratio	1Y return	3Y return	3Y alpha	3Y beta	3Y Sharpe	3Y Sortino
Nippon India Taiwan Equity Fund	1/133	1,147	1.08%	+75.71%	+54.78%	--	--	1.38	2.03	Compare
HDFC Defence Fund	2/133	11,493	0.90%	+13.79%	+34.76%	−0.18%	0.83	1.12	1.54	Compare
HDFC Pharma and Healthcare Fund	3/133	3,501	1.05%	+23.12%	+30.53%	+8.23%	0.96	1.74	2.49	Compare
SBI Healthcare Opportunities Fund	4/133	5,870	1.01%	+17.12%	+24.60%	+3.61%	0.88	1.42	2.03	Compare
Aditya Birla Sun Life International Equity Fund	5/133	352	2.00%	+13.97%	+24.46%	--	--	1.49	2.16	Compare
UTI - Healthcare Fund	8/133	1,430	1.35%	+13.46%	+23.47%	+1.87%	0.92	1.30	1.84

AUM is each fund's size at the end of its last reported month, from its own portfolio file. We calculate the risk ratios from daily NAVs over the last three years. The risk-free return is what NSE's overnight rate index earned over the same years. Alpha and beta compare each fund with its own benchmark's TRI. "--" means we have no figure: for alpha and beta, no daily series for that benchmark.

UTI - Healthcare Fund Expense Ratio and Costs

What each plan charges a year, in force from 19-10-2026

Plan	Base expense ratio	Brokerage	Transaction costs	Levies and GST	Total expense ratio	Thematic median	Cost rank (1 = cheapest)
Direct	1.06%	0.03%	0.00%	0.26%	1.35%	1.18%	161/235
Regular	1.84%	0.03%	0.00%	0.36%	2.23%	2.41%	77/235

The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, the cost of executing trades, and statutory levies with GST. From AMFI's expense ratio file. Cost rank: where this plan comes when the Thematic funds' plans of the same type are sorted from the lowest total expense ratio to the highest.

Direct vs Regular: what the gap cost

Both plans own the same portfolio, so the difference in what they earned is the Regular plan's extra cost, taken out of its NAV.

Over the last	Regular	Direct	Direct earned more by	₹1 lakh became (Regular)	₹1 lakh became (Direct)
1 year	12.39%	13.46%	1.07%	₹1,12,390	₹1,13,460
3 years	22.28%	23.47%	1.19% a year	₹1,82,838	₹1,88,228
5 years	15.06%	16.24%	1.18% a year	₹2,01,661	₹2,12,216
10 years	13.26%	14.40%	1.14% a year	₹3,47,349	₹3,83,937

Returns over more than 1 year are a rate a year (CAGR). ₹1 lakh invested once at the start of each period, valued on the last NAV.

UTI - Healthcare Fund SIP Calculator

What a one-time or monthly investment in this fund would be worth today, from its own NAV history

Growth of an investment

Every month₹

Step up each year

PeriodFor

₹10,000 on the first trading day of every month, from 02-01-2013 to 30-10-2026: 166 instalments, ₹16,60,000 in all.

Investment	Invested	Value now	Gain	Return a year
Direct planUTI - Healthcare Fund (Direct)	₹16,60,000	₹56,32,303	₹39,72,303	16.3%
Regular planUTI - Healthcare Fund (Regular)	₹16,60,000	₹51,63,877	₹35,03,877	15.2%
BSE Healthcare TRI	₹16,60,000	₹50,28,835	₹33,68,835	14.8%
Category averageCategory average, 235 Thematic funds	₹16,60,000	₹52,02,269	₹35,42,269	15.2%

₹0₹20.0 L₹40.0 L₹60.0 L

2014201620182020202220242026

Direct planUTI - Healthcare Fund (Direct)Regular planUTI - Healthcare Fund (Regular)BSE Healthcare TRICategory averageCategory average, 235 Thematic fundsAmount invested

From each plan's published NAV (Growth option), the benchmark's TRI and the category average, over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.

UTI - Healthcare Fund Asset Allocation

Asset allocation as on 30-09-2026

What the fund holds

94.2%Equity

Asset	Fund	Category
Equity	94.2%	94.5%
Cash and others	5.8%	4.0%

Market cap of stocks

Market cap	Fund	Category
Large Cap	18.2%	45.7%
Mid Cap	33.6%	19.6%
Small Cap	39.2%	24.1%
Not on AMFI's list	3.1%	2.3%

Share of the whole fund. Category: the average of the Thematic funds that hold stocks. Groups follow AMFI's latest list, as SEBI defines them: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.

UTI - Healthcare Fund Sector Allocation

Sector allocation of the fund's stocks as on 30-09-2026

Largest sectors

Pharmaceuticals & Biotechnology68.5%
Healthcare Services23.3%
Chemicals & Petrochemicals1.3%
Healthcare Equipment & Supplies1.1%

Sector changes

Sector	July 2026	August 2026	September 2026	Change
Pharmaceuticals & Biotechnology	69.5%	67.9%	68.5%	−1.0%
Healthcare Services	23.9%	24.0%	23.3%	−0.7%
Chemicals & Petrochemicals	1.7%	1.4%	1.3%	−0.4%
Healthcare Equipment & Supplies	1.0%	1.0%	1.1%	+0.1%

Each sector's share of the fund at the end of each month. The five largest sectors of September 2026. Change: from July 2026 to September 2026, in % of the fund.

UTI - Healthcare Fund Portfolio Holdings

As on 30-09-2026 · 44 holdings · from the fund house's monthly portfolio

Holdings	Sector	Weight%	1M change
EQ - SUN PHARMACEUTICALS INDUSTRIES	Pharmaceuticals & Biotechnology	7.62%	0.0%
EQ - DIVIS LABORATORIES LTD.	Pharmaceuticals & Biotechnology	6.15%	0.0%
EQ - DR REDDYS LABORATORIES LTD.	Pharmaceuticals & Biotechnology	5.24%	+34.0%
EQ - AJANTA PHARMA LTD.	Pharmaceuticals & Biotechnology	4.81%	0.0%
EQ - GLAND PHARMA LTD.	Pharmaceuticals & Biotechnology	4.06%	+8.1%
EQ - ALKEM LABORATORIES LTD	Pharmaceuticals & Biotechnology	3.70%	+15.2%
EQ - APOLLO HOSPITALS ENTERPRISE LT	Healthcare Services	3.03%	0.0%
EQ - CAPLIN POINT LABORATORIES LTD	Pharmaceuticals & Biotechnology	3.02%	−9.0%
EQ- GLOBAL HEALTH LTD.	Healthcare Services	2.96%	+13.0%
EQ - LUPIN LTD.	Pharmaceuticals & Biotechnology	2.89%	0.0%
EQ - IPCA LABORATORIES LTD.	Pharmaceuticals & Biotechnology	2.81%	−0.6%
EQ - MAX HEALTHCARE INSTITUTE LTD	Healthcare Services	2.80%	0.0%
EQ - COHANCE LIFESCIENCES LIMITED	Pharmaceuticals & Biotechnology	2.79%	+28.6%
EQ - MARKSANS PHARMA LTD.	Pharmaceuticals & Biotechnology	2.25%	0.0%
EQ - RAINBOW CHILDRENS MEDICARE LTD	Healthcare Services	2.21%	+4.3%
EQ - GLENMARK PHARMACEUTICALS LTD.	Pharmaceuticals & Biotechnology	2.12%	0.0%
EQ- JUPITER LIFE LINE HOSPITALS LTD	Healthcare Services	2.09%	+11.0%
EQ - AUROBINDO PHARMA LTD.	Pharmaceuticals & Biotechnology	2.07%	0.0%
EQ - FORTIS HEALTHCARE LTD.	Healthcare Services	2.02%	0.0%
EQ - PROCTOR & GAMBLE HEALTH LTD	Pharmaceuticals & Biotechnology	1.95%	0.0%
EQ - ANTHEM BIOSCIENCES LTD	Pharmaceuticals & Biotechnology	1.80%	−29.1%
EQ - ASTER DM QUALITY CARE LIMITED	Healthcare Services	1.76%	0.0%
EQ - DR LAL PATHLABS LTD.	Healthcare Services	1.67%	0.0%
EQ - BIOCON LTD.	Pharmaceuticals & Biotechnology	1.62%	+25.5%
EQ - METROPOLIS HEALTHCARE LTD	Healthcare Services	1.47%	0.0%
EQ - WINDLAS BIOTEC LTD	Pharmaceuticals & Biotechnology	1.42%	−0.3%
EQ - BLUE JET HEALTHCARE LTD	Pharmaceuticals & Biotechnology	1.41%	+51.8%
EQ - CIPLA LTD.	Pharmaceuticals & Biotechnology	1.41%	0.0%
EQ - ALEMBIC PHARMACEUTICALS	Pharmaceuticals & Biotechnology	1.40%	+21.4%
EQ - VIYASH SCIENTIFIC LTD	Pharmaceuticals & Biotechnology	1.39%	0.0%
EQ - VIJAYA DIAGNOSTIC CENTRE LTD	Healthcare Services	1.33%	0.0%
EQ - SUDEEP PHARMA LIMITED	Chemicals & Petrochemicals	1.28%	−10.6%
EQ - SAI LIFE SCIENCES LTD	Pharmaceuticals & Biotechnology	1.26%	−33.4%
EQ - ERIS LIFESCIENCES LTD	Pharmaceuticals & Biotechnology	1.13%	0.0%
EQ - LAXMI DENTAL LIMITED	Healthcare Equipment & Supplies	1.08%	+10.5%
EQ - MANIPAL HEALTH ENTERPRISES LIMITED	Healthcare Services	1.05%	0.0%
EQ - AARTI PHARMALABS LTD	Pharmaceuticals & Biotechnology	1.00%	0.0%
EQ - PFIZER LIMITED	Pharmaceuticals & Biotechnology	0.93%	0.0%
EQ - ORCHID PHARMA LTD.	Pharmaceuticals & Biotechnology	0.71%	0.0%
EQ - SANOFI CONSUMER HEALTHCARE INDIA LTD	Pharmaceuticals & Biotechnology	0.67%	+4.5%
EQ - JUBILANT PHARMOVA LIMITED	Pharmaceuticals & Biotechnology	0.65%	0.0%
EQ - INDEGENE LTD	Healthcare Services	0.50%	New
EQ - SYNGENE INTERNATIONAL LTD.	Healthcare Services	0.42%	0.0%
EQ - EMCURE PHARMACEUTICALS LTD	Pharmaceuticals & Biotechnology	0.20%	−78.3%

UTI - Healthcare Fund Stocks Bought and Sold

All changes are between August 2026 and September 2026

Stocks bought and sold in September 2026

EQ - DR REDDYS LABORATORIES LTD.	Added	+34.0%	5.24%
EQ - GLAND PHARMA LTD.	Added	+8.1%	4.06%
EQ - ALKEM LABORATORIES LTD	Added	+15.2%	3.70%
EQ - CAPLIN POINT LABORATORIES LTD	Reduced	−9.0%	3.02%
EQ- GLOBAL HEALTH LTD.	Added	+13.0%	2.96%
EQ - IPCA LABORATORIES LTD.	Reduced	−0.6%	2.81%
EQ - COHANCE LIFESCIENCES LIMITED	Added	+28.6%	2.79%
EQ - ANTHEM BIOSCIENCES LTD	Reduced	−29.1%	1.80%
EQ - RAINBOW CHILDRENS MEDICARE LTD	Added	+4.3%	2.21%
EQ- JUPITER LIFE LINE HOSPITALS LTD	Added	+11.0%	2.09%
EQ - SAI LIFE SCIENCES LTD	Reduced	−33.4%	1.26%
EQ - BIOCON LTD.	Added	+25.5%	1.62%
EQ - WINDLAS BIOTEC LTD	Reduced	−0.3%	1.42%
EQ - SUDEEP PHARMA LIMITED	Reduced	−10.6%	1.28%
EQ - BLUE JET HEALTHCARE LTD	Added	+51.8%	1.41%
EQ - ALEMBIC PHARMACEUTICALS	Added	+21.4%	1.40%
EQ - LAXMI DENTAL LIMITED	Added	+10.5%	1.08%
EQ - EMCURE PHARMACEUTICALS LTD	Reduced	−78.3%	0.20%
EQ - SANOFI CONSUMER HEALTHCARE INDIA LTD	Added	+4.5%	0.67%
EQ - INDEGENE LTD	New	New	0.50%

A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.

What UTI - Healthcare Fund bought and sold

UTI - Healthcare Fund Portfolio Overlap

Funds with the most similar portfolios, across every fund house and category

Fund	Overlap	Holdings in common
Motilal Oswal BSE Healthcare ETFETF · Motilal Oswal	53.8%	42	Compare
Bandhan BSE Healthcare Index FundIndex · Bandhan	53.6%	42	Compare
HDFC Pharma and Healthcare FundThematic · HDFC	53.2%	23	Compare
ITI Pharma and Healthcare FundThematic · ITI	52.5%	23	Compare
Mirae Asset Nifty 500 Healthcare ETFETF · Mirae Asset	52.1%	26	Compare
Mirae Asset Healthcare FundThematic · Mirae Asset	51.4%	19	Compare
Nippon India Pharma FundSectoral · Nippon India	51.3%	22	Compare
Aditya Birla Sun Life Pharma and Healthcare FundThematic · Aditya Birla Sun Life	49.7%	27	Compare

Overlap: for each holding both funds own, the smaller of its two weights, added up. 40% means 40% of each fund's money sits in positions the other also holds. From each fund's latest monthly portfolio, matched by ISIN. Cash and hedged positions are left out. Funds that overlap under 10% are not listed. A high overlap does not make two funds the same: their costs, lock-in and category can differ.

UTI - Healthcare Fund Overview

Fund facts from the scheme summary document, as on 16-10-2026

Expense ratio (Direct): 1.35%
Expense ratio (Regular): 2.23%
Category: Thematic
Risk: Very High
Benchmark: BSE Healthcare TRI
Launch date: 28-06-1999
AUM: ₹1,429.84 Cr (30-09-2026)
Lock in: None
Scheme code (Direct): 120782
ISIN (Direct): INF789F01TO9
Scheme code (Regular): 100807
ISIN (Regular): INF789F01695
NAV history: From 02-01-2013, 13.8 years

Minimum investment: Regular Plan-Growth- Rs.5000, Regular Plan-Reinvestment of IDCW- Rs.5000, Regular Plan-Payout of IDCW- Rs.5000, Direct Plan-Growth- Rs.5000, Direct Plan-Reinvestment of IDCW- Rs.5000, Direct Plan-Payout of IDCW- Rs.5000,
Minimum additional investment: Regular Plan-Growth-Rs.1000, Regular Plan-Reinvestment of IDCW-Rs.1000, Regular Plan-Payout of IDCW-Rs.1000, Direct Plan-Growth-Rs.1000, Direct Plan-Reinvestment of IDCW-Rs.1000, Direct Plan-Payout of IDCW-Rs.1000,
Exit load: 1.00% if redeemed before 30 days from the date of allotment. Nil if redeemed on or after 30 days from the date of allotment

Tax on UTI - Healthcare Fund returns

UTI - Healthcare Fund is taxed as an equity fund: 65% or more of it is in Indian stocks.
Units sold within 1 year: the gain is taxed at 20%.
Units held longer: gains above ₹1.25 lakh in a financial year, across all your equity funds and shares, are taxed at 12.5%.
IDCW (dividend) payouts are added to your income and taxed at your slab rate.
A stamp duty of 0.005% is deducted when you invest.

Rules in force from 23-07-2024 (Finance Act 2024). Tax depends on your own income; this is general information, not tax advice.

All plans and options

Plan	Option	NAV	As on
direct	Growth	₹375.0929	30-10-2026
direct	IDCW	₹289.9193	30-10-2026
regular	Growth	₹328.6163	30-10-2026
regular	IDCW	₹253.9745	30-10-2026

About UTI - Healthcare Fund

UTI - Healthcare Fund is a mutual fund from UTI Mutual Fund. Its category is Thematic. It was launched on 28-06-1999. Its benchmark is BSE Healthcare TRI. At the end of September 2026 it held 44 securities.

Fund Manager

Kamal Gada FM 1
Fund manager of UTI - Healthcare Fund
Not Applicable FM 2
Fund manager of UTI - Healthcare Fund
Not Applicable FM 3
Fund manager of UTI - Healthcare Fund

See all funds of UTI Mutual Fund

AUM change

September 2026: ₹1,429.84 Cr; −0.95% from August 2026
August 2026: ₹1,443.57 Cr; +5.30% from July 2026
July 2026: ₹1,370.92 Cr; +4.81% from June 2026

AUM moves with money invested or taken out, and with the value of what the fund holds.

Compare UTI - Healthcare Fund with Other Funds

Returns, risk, costs and the stocks they share, side by side

UTI - Healthcare vs Nippon India Taiwan EquityThematic
UTI - Healthcare vs HDFC DefenceThematic
UTI - Healthcare vs HDFC Pharma and Healthcare53.2% overlap
UTI - Healthcare vs SBI Healthcare OpportunitiesThematic
UTI - Healthcare vs Aditya Birla Sun Life International EquityThematic
UTI - Healthcare vs Motilal Oswal BSE Healthcare ETF53.8% overlap
UTI - Healthcare vs Bandhan BSE Healthcare Index53.6% overlap
UTI - Healthcare vs ITI Pharma and Healthcare52.5% overlap

Compare with any other fund

Frequently Asked Questions for UTI - Healthcare Fund

What is the current NAV of UTI - Healthcare Fund?

The Direct plan NAV is ₹375.0929. The Regular plan NAV is ₹328.6163, as on 30-10-2026.

What are the returns of UTI - Healthcare Fund?

The Direct plan returned +13.46% in 1 year, +23.47% a year over 3 years, +16.24% a year over 5 years. The Regular plan returned +12.39% in 1 year, +22.28% a year over 3 years, +15.06% a year over 5 years. These figures are as on 30-10-2026.

What is the expense ratio of UTI - Healthcare Fund?

The Direct plan charges 1.35% a year. The Regular plan charges 2.23% a year. This is the figure the fund house reported to AMFI, in force from 19-10-2026.

What is the AUM of UTI - Healthcare Fund?

UTI - Healthcare Fund managed ₹1,429.84 Cr on 30-09-2026, as its fund house reported in its monthly portfolio.

What are the top holdings of UTI - Healthcare Fund?

At the end of September 2026 the largest holdings were SUNPHARMA (7.62%), DIVISLAB (6.15%), DRREDDY (5.24%), AJANTPHARM (4.81%), GLAND (4.06%). The fund held 44 securities in all.

What did UTI - Healthcare Fund buy and sell in September 2026?

It bought 1 new stock: EQ - INDEGENE LTD. It added shares in 12. It reduced 7.

How do I invest in UTI - Healthcare Fund?

Through UTI Mutual Fund's website or app, a mutual fund distributor, or an investment platform. Choose the Direct plan to pay no distributor commission, or the Regular plan to invest through a distributor. The first investment is at least Regular Plan-Growth- Rs.5000, Regular Plan-Reinvestment of IDCW- Rs.5000, Regular Plan-Payout of IDCW- Rs.5000, Direct Plan-Growth- Rs.5000, Direct Plan-Reinvestment of IDCW- Rs.5000, Direct Plan-Payout of IDCW- Rs.5000,. You can invest once or through a monthly SIP.

Who is the fund manager of UTI - Healthcare Fund?

Kamal Gada FM 1, Not Applicable FM 2, Not Applicable FM 3.

Sources: NAV and expense ratio from AMFI. Holdings from the fund house's monthly portfolio statement. Fund facts from its scheme summary document, as on 16-10-2026.

This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.